- Coproxamol - Unlicensed use fact sheet - April 2018
- Coproxamol - Changes to prescribing - April 2018
- Dosulepin - Changes to Prescribing - August 2018
- Doxazosin - Changes to Prescribing - April 2018
- Doxazosin Fact sheet April 2018
- Glucosamine - changes to prescribing April 2018
- Herbal meds - Changes to prescribing April 2018
- Homeopathy - Changes to prescribing April 2018
- Immediate release fentanyl (DROP - List)
- Immediate-release fentanyl - Changes to prescribing August 2018
- Omega-3 Prescribing Fact sheet July 2018
- Once-daily tadalafil -Changes to prescribing April 2018
- Oxycodone naloxone prolonged release (Targinact) tablets
- Perindopril arginine - Changes to prescribing April 2018
- Rubefacients - Changes to prescribing August 2018
- Tramacet - changes to prescribing August 2018
- Trimipramine - Changes to prescribing August 2018
- Weblinks to SEL NHSE POMS position statements May 2022
SEL IMOC homeAdult guidelines and pathwaysAnnual reports and work plansCardiovascular disease guidanceCommittee governanceCommittee minutesDiabetes guidanceFormulary recommendations and position statementsLow priority products (NHS England)Paediatric guidelines and pathwaysPoliciesRed, Amber, Green, Grey (RAGG) list definitionsRegional Medicines Optimisation Committee (RMOC) guidanceSelf care (over the counter medicines)Shared care agreements and templatesSupporting information for primary care for significant medicines shortagesTemplate letters
